EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+10.4%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$970M
AUM Growth
+$970M
Cap. Flow
-$13.8M
Cap. Flow %
-1.42%
Top 10 Hldgs %
72%
Holding
47
New
11
Increased
8
Reduced
10
Closed
10
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CRIS icon
26
Curis
CRIS
$20.9M
$5.55M 0.56% 2,982,208
NGNE icon
27
Neurogene
NGNE
$264M
$5.35M 0.54% 2,265,880
RYTM icon
28
Rhythm Pharmaceuticals
RYTM
$6.85B
$4.91M 0.5% 223,167 -177,671 -44% -$3.91M
SLDB icon
29
Solid Biosciences
SLDB
$427M
$4.76M 0.48% +827,000 New +$4.76M
NGM
30
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$4.64M 0.47% +316,900 New +$4.64M
KZR icon
31
Kezar Life Sciences
KZR
$28.9M
$4.5M 0.45% 583,293 -273,178 -32% -$2.11M
KDNY
32
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2.71M 0.27% 1,761,421 -177,969 -9% -$274K
VCEL icon
33
Vericel Corp
VCEL
$1.83B
$2.48M 0.25% 131,001
SYRS
34
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.3M 0.23% +248,480 New +$2.3M
RGLS
35
DELISTED
Regulus Therapeutics
RGLS
$1.39M 0.14% +1,111,110 New +$1.39M
GMDA
36
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$265K 0.03% +52,120 New +$265K
TCRR
37
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$231K 0.02% +16,114 New +$231K
ABUS icon
38
Arbutus Biopharma
ABUS
$711M
-2,172,883 Closed -$7.78M
ARVN icon
39
Arvinas
ARVN
$568M
-50,000 Closed -$738K
ASMB icon
40
Assembly Biosciences
ASMB
$190M
-1,153,599 Closed -$22.7M
ASND icon
41
Ascendis Pharma
ASND
$11.8B
-360,819 Closed -$42.5M
DNTH icon
42
Dianthus Therapeutics
DNTH
$759M
-1,277,787 Closed -$21M
RCKT icon
43
Rocket Pharmaceuticals
RCKT
$354M
-450,000 Closed -$7.89M
SRRK icon
44
Scholar Rock
SRRK
$3.14B
-338,668 Closed -$6.36M
ZLAB icon
45
Zai Lab
ZLAB
$3.68B
-78,519 Closed -$2.32M
SNNA
46
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
-800,000 Closed -$1.86M
MYOK
47
DELISTED
MyoKardia, Inc. Common Stock
MYOK
-478,574 Closed -$24.9M